Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial

Sexual dysfunction commonly occurs with major depressive disorder (MDD). Vilazodone, a selective serotonin reuptake inhibitor and 5-HT(1A) receptor partial agonist antidepressant approved for the treatment of MDD in adults, was evaluated to determine its effects on sexual function. The primary study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int Clin Psychopharmacol
Hauptverfasser: Clayton, Anita H., Gommoll, Carl, Chen, Dalei, Nunez, Rene, Mathews, Maju
Format: Artigo
Sprache:Inglês
Veröffentlicht: Lippincott Williams And Wilkins 2015
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457500/
https://ncbi.nlm.nih.gov/pubmed/26039688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000075
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge